Matches in Wikidata for { <http://www.wikidata.org/entity/Q62040259> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q62040259 description "assaig clínic" @default.
- Q62040259 description "clinical trial" @default.
- Q62040259 description "clinical trial" @default.
- Q62040259 description "clinical trial" @default.
- Q62040259 description "clinical trial" @default.
- Q62040259 description "ensaio clínico" @default.
- Q62040259 description "ensayo clínico" @default.
- Q62040259 description "ensayu clínicu" @default.
- Q62040259 description "essai clinique" @default.
- Q62040259 description "klinisch onderzoek" @default.
- Q62040259 description "клінічне випробування" @default.
- Q62040259 description "临床试验" @default.
- Q62040259 name "A Study of Mirikizumab in Participants With Plaque Psoriasis" @default.
- Q62040259 type Item @default.
- Q62040259 label "A Study of Mirikizumab in Participants With Plaque Psoriasis" @default.
- Q62040259 prefLabel "A Study of Mirikizumab in Participants With Plaque Psoriasis" @default.
- Q62040259 P1050 Q62040259-DD9835B8-9873-4A20-8228-C53030A3FE60 @default.
- Q62040259 P1132 Q62040259-5A796605-E9BB-41DD-AC2C-26E39B5EC626 @default.
- Q62040259 P1476 Q62040259-D8017BF3-D88C-4BA4-AF13-E5D8092E105D @default.
- Q62040259 P17 Q62040259-D0EA39F6-C3A2-4BCE-AF6A-A943EB32250A @default.
- Q62040259 P3098 Q62040259-3D78B8E8-3C65-418E-A287-478678306386 @default.
- Q62040259 P31 Q62040259-35450777-12E3-482D-BD9E-50C3F179A08D @default.
- Q62040259 P580 Q62040259-BB426301-7B7A-40B6-9997-FA3252B27AEE @default.
- Q62040259 P582 Q62040259-FB974D36-7869-4F5B-B962-F0B4EA99C169 @default.
- Q62040259 P6099 Q62040259-0F6F9E18-1EDA-45FB-9E6D-379BB2F851F7 @default.
- Q62040259 P8005 Q62040259-6C7AD5AD-D353-4AB2-89B0-AC789490D63B @default.
- Q62040259 P8363 Q62040259-2F8889A6-2EC6-475C-A7AF-66A4B2310DC0 @default.
- Q62040259 P859 Q62040259-9E13CFD8-9981-424B-929E-2ADA67D8393C @default.
- Q62040259 P1050 Q179945 @default.
- Q62040259 P1132 "+30" @default.
- Q62040259 P1476 "Evaluation of the Effect of Mirikizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients With Moderate-to-Severe Plaque Psoriasis" @default.
- Q62040259 P17 Q30 @default.
- Q62040259 P3098 "NCT03718884" @default.
- Q62040259 P31 Q30612 @default.
- Q62040259 P580 "2018-10-23T00:00:00Z" @default.
- Q62040259 P582 "2019-09-22T00:00:00Z" @default.
- Q62040259 P6099 Q5452194 @default.
- Q62040259 P8005 Q76651189 @default.
- Q62040259 P8363 Q78089383 @default.
- Q62040259 P859 Q632240 @default.